Interested in becoming an advocate?
Zepbound®
Once a week subcutaneous injection
Ozempic (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.
Zepbound (generic name: Tirzepatide) is a GLP-1/GIP receptor agonist drug that can result in substantial weight loss. It is FDA approved to help adults with overweight or obesity.
How does
Zepbound®
work:
- acts on brain signaling to reduce food intake
- helps control blood sugar levels by increasing the release of insulin from the pancreas
- slows down food leaving your stomach, thus, keeping you fuller for longer
Common side effects of
Zepbound®
- nausea
- vomiting
- decreased appetite
- diarrhea
- stomach (abdominal) pain
- constipation
You can find more information here:
Expected Results:
- Individuals on Zepbound lost an average of 21% of their body weight
- Helps control blood sugar levels
- Decreased HgbA1C
Do not take
Zepbound®
if you:
- have or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have MEN2
- are pregnant, planning to become pregnant or breastfeeding
- have or have had history of pancreatitis
- history of chronic malabsorption
- history of gallbladder disease
- have a history of gastroparesis or IBD
- are allergic to tirzepatide or any of the ingredients* in Zepbound
*non-medicinal ingredients in Zepbound: sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection. Hydrochloric acid solution and/or sodium hydroxide solution may have been added to adjust the pH.
Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.